Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -12.77% |
| 2024 | -0.09% |
| 2023 | 14.76% |
| 2022 | 11.15% |
| 2021 | 65.03% |
| 2020 | 98.37% |
| 2019 | -38.48% |
| 2018 | 171.82% |
| 2017 | 41.35% |
| 2016 | 7.31% |